176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.66%
Some net income increase while MRVL is negative at -29.15%. John Neff would see a short-term edge over the struggling competitor.
-2.75%
Both reduce yoy D&A, with MRVL at -0.84%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-13.80%
Negative yoy deferred tax while MRVL stands at 158250.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
2.50%
Less SBC growth vs. MRVL's 10.70%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
253.87%
Slight usage while MRVL is negative at -79.54%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
196.15%
AR growth while MRVL is negative at -51.87%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-268.49%
Negative yoy inventory while MRVL is 28.64%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-149.98%
Negative yoy AP while MRVL is 14.05%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
452.03%
Some yoy usage while MRVL is negative at -1617.21%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
49.95%
Well above MRVL's 71.84%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
105.33%
Some CFO growth while MRVL is negative at -20.15%. John Neff would note a short-term liquidity lead over the competitor.
21.88%
CapEx growth well above MRVL's 25.00%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-65.99%
Negative yoy purchasing while MRVL stands at 23.30%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-4.07%
We reduce yoy sales while MRVL is 20.68%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-114700.00%
We reduce yoy other investing while MRVL is 94.37%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-1940.25%
We reduce yoy invests while MRVL stands at 57.66%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-2.71%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
98.84%
Repurchase growth above 1.5x MRVL's 52.32%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.